Cargando…

Amifampridine for Lambert-Eaton myasthenic syndrome

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: NPS MedicineWise 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9584795/
https://www.ncbi.nlm.nih.gov/pubmed/36382167
http://dx.doi.org/10.18773/austprescr.2022.056
_version_ 1784813351804600320
collection PubMed
description
format Online
Article
Text
id pubmed-9584795
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher NPS MedicineWise
record_format MEDLINE/PubMed
spelling pubmed-95847952022-11-14 Amifampridine for Lambert-Eaton myasthenic syndrome Aust Prescr New Drugs NPS MedicineWise 2022-09-01 2022-10 /pmc/articles/PMC9584795/ /pubmed/36382167 http://dx.doi.org/10.18773/austprescr.2022.056 Text en (c) NPS MedicineWise https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (CC BY-NC-ND) 4.0 License.
spellingShingle New Drugs
Amifampridine for Lambert-Eaton myasthenic syndrome
title Amifampridine for Lambert-Eaton myasthenic syndrome
title_full Amifampridine for Lambert-Eaton myasthenic syndrome
title_fullStr Amifampridine for Lambert-Eaton myasthenic syndrome
title_full_unstemmed Amifampridine for Lambert-Eaton myasthenic syndrome
title_short Amifampridine for Lambert-Eaton myasthenic syndrome
title_sort amifampridine for lambert-eaton myasthenic syndrome
topic New Drugs
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9584795/
https://www.ncbi.nlm.nih.gov/pubmed/36382167
http://dx.doi.org/10.18773/austprescr.2022.056